5 Best Value ETFs To Invest In

2. Invesco S&P 500 Enhanced Value ETF (NYSE:SPVU)

The Invesco S&P 500 Enhanced Value ETF (NYSE:SPVU) is based on the S&P 500 Enhanced Value Index and tracks the performance of stocks in the S&P 500 Index that have the highest “value score.” The fund generally will invest at least 90% of its total assets in common stocks that comprise the index. The fund tends to dip deeper when value is weak, but also explodes higher when value is back in style. That includes its performance in 2020, when it dropped peak-to-trough by 10% more than its peers, but also since then, rebounding by about 35% better. The fund’s portfolio is split roughly 70/30 between large and mid-cap stocks, and it has a heavy overweight in the financials sector, followed by the healthcare sector.

CVS Health Corporation (NYSE:CVS) is one of the main holdings of Invesco S&P 500 Enhanced Value ETF (NYSE:SPVU). It operates a network of retail pharmacies and clinics across the United States. The brands that operate under the company include CVS Pharmacy, CVS Caremark, MinuteClinic, and Omnicare. On June 16, Loop Capital analyst Joseph France initiated coverage of CVS Health Corporation (NYSE:CVS) with a Buy rating and $120 price target. The company is well-positioned in its core markets, and with less debt and stronger earnings growth, it can afford more strategic acquisitions, the analyst tells investors in a research note. France also expects CVS Health Corporation (NYSE:CVS)’s insurance business to capitalize on the growth of the Medicare market.

Of the 912 elite hedge funds tracked by Insider Monkey, 72 reported holding shares of CVS Health Corporation (NYSE:CVS), with combined positions worth $1.56 billion. This is in comparison to 71 hedge funds a quarter earlier. Harris Associates was the biggest shareholder of CVS Health Corporation (NYSE:CVS) at the end of the first quarter, with a stake worth $421 million.

Here is what ClearBridge Investments had to say about CVS Health Corporation (NYSE:CVS) in its Q4 2021 investor letter:

“Improving health remains a key impact theme for the portfolio, and over the past year or so we have increased our exposure to the health care sector, through the addition of CVS Health, which is well-positioned to help define the future of health care in terms of costs, quality and convenience.”